rs11214077

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM5BP4_StrongBP6_Very_StrongBS1BS2

The NM_003002.4(SDHD):​c.149A>G​(p.His50Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00735 in 1,609,602 control chromosomes in the GnomAD database, including 54 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H50D) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.0068 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0074 ( 48 hom. )

Consequence

SDHD
NM_003002.4 missense

Scores

3
9
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:2B:25O:1

Conservation

PhyloP100: 2.52

Publications

58 publications found
Variant links:
Genes affected
SDHD (HGNC:10683): (succinate dehydrogenase complex subunit D) This gene encodes a member of complex II of the respiratory chain, which is responsible for the oxidation of succinate. The encoded protein is one of two integral membrane proteins anchoring the complex to the matrix side of the mitochondrial inner membrane. Mutations in this gene are associated with the formation of tumors, including hereditary paraganglioma. Transmission of disease occurs almost exclusively through the paternal allele, suggesting that this locus may be maternally imprinted. There are pseudogenes for this gene on chromosomes 1, 2, 3, 7, and 18. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2013]
SDHD Gene-Disease associations (from GenCC):
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • pheochromocytoma/paraganglioma syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • Carney-Stratakis syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • mitochondrial complex II deficiency, nuclear type 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • renal cell carcinoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • mitochondrial complex 2 deficiency, nuclear type 3
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
  • mitochondrial complex II deficiency
    Inheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intestinal cancer
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • mitochondrial disease
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_003002.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chr11-112087952-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 431847.
BP4
Computational evidence support a benign effect (MetaRNN=0.00989148).
BP6
Variant 11-112087953-A-G is Benign according to our data. Variant chr11-112087953-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 6909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00679 (1034/152244) while in subpopulation AMR AF = 0.0155 (237/15302). AF 95% confidence interval is 0.0139. There are 6 homozygotes in GnomAd4. There are 482 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003002.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SDHD
NM_003002.4
MANE Select
c.149A>Gp.His50Arg
missense
Exon 2 of 4NP_002993.1O14521-1
SDHD
NM_001276506.2
c.149A>Gp.His50Arg
missense
Exon 2 of 5NP_001263435.1O14521-4
SDHD
NM_001276503.2
c.149A>Gp.His50Arg
missense
Exon 2 of 3NP_001263432.1A0A0S2Z4H7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SDHD
ENST00000375549.8
TSL:1 MANE Select
c.149A>Gp.His50Arg
missense
Exon 2 of 4ENSP00000364699.3O14521-1
SDHD
ENST00000528048.5
TSL:1
c.149A>Gp.His50Arg
missense
Exon 2 of 3ENSP00000436217.1O14521-3
ENSG00000255292
ENST00000532699.1
TSL:3
n.149A>G
non_coding_transcript_exon
Exon 2 of 6ENSP00000456434.1H3BRW5

Frequencies

GnomAD3 genomes
AF:
0.00680
AC:
1035
AN:
152126
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00212
Gnomad AMI
AF:
0.0164
Gnomad AMR
AF:
0.0156
Gnomad ASJ
AF:
0.00894
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00669
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.00796
Gnomad OTH
AF:
0.0187
GnomAD2 exomes
AF:
0.00661
AC:
1661
AN:
251460
AF XY:
0.00670
show subpopulations
Gnomad AFR exome
AF:
0.00148
Gnomad AMR exome
AF:
0.00734
Gnomad ASJ exome
AF:
0.00833
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00638
Gnomad NFE exome
AF:
0.00913
Gnomad OTH exome
AF:
0.0112
GnomAD4 exome
AF:
0.00741
AC:
10795
AN:
1457358
Hom.:
48
Cov.:
29
AF XY:
0.00729
AC XY:
5289
AN XY:
725300
show subpopulations
African (AFR)
AF:
0.00141
AC:
47
AN:
33384
American (AMR)
AF:
0.00827
AC:
370
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00877
AC:
229
AN:
26106
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39682
South Asian (SAS)
AF:
0.00183
AC:
158
AN:
86180
European-Finnish (FIN)
AF:
0.00673
AC:
359
AN:
53376
Middle Eastern (MID)
AF:
0.00573
AC:
33
AN:
5764
European-Non Finnish (NFE)
AF:
0.00822
AC:
9107
AN:
1107874
Other (OTH)
AF:
0.00816
AC:
492
AN:
60274
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
496
993
1489
1986
2482
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
338
676
1014
1352
1690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00679
AC:
1034
AN:
152244
Hom.:
6
Cov.:
32
AF XY:
0.00647
AC XY:
482
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.00212
AC:
88
AN:
41546
American (AMR)
AF:
0.0155
AC:
237
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00894
AC:
31
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4824
European-Finnish (FIN)
AF:
0.00669
AC:
71
AN:
10612
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.00796
AC:
541
AN:
67992
Other (OTH)
AF:
0.0185
AC:
39
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
52
103
155
206
258
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00776
Hom.:
26
Bravo
AF:
0.00776
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00981
EpiControl
AF:
0.0100

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
8
not provided (9)
-
-
5
not specified (6)
-
-
3
Hereditary cancer-predisposing syndrome (3)
-
-
2
Hereditary pheochromocytoma and paraganglioma (2)
-
-
2
Pheochromocytoma/paraganglioma syndrome 1 (2)
-
1
-
Carcinoid tumor of intestine (1)
-
-
1
Carney-Stratakis syndrome (1)
-
-
1
Carney-Stratakis syndrome;C3494181:Pheochromocytoma/paraganglioma syndrome 1;C5436934:Mitochondrial complex 2 deficiency, nuclear type 3 (1)
-
-
1
Pheochromocytoma (1)
-
-
1
Pheochromocytoma;C1847319:Carney-Stratakis syndrome;C1868633:Paragangliomas with sensorineural hearing loss;CN166604:Cowden syndrome 3 (1)
-
-
1
SDHD-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
0.0027
T
BayesDel_noAF
Pathogenic
0.24
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.60
D
Eigen
Uncertain
0.49
Eigen_PC
Uncertain
0.42
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.88
D
MetaRNN
Benign
0.0099
T
MetaSVM
Uncertain
0.69
D
MutationAssessor
Uncertain
2.9
M
PhyloP100
2.5
PrimateAI
Uncertain
0.51
T
PROVEAN
Benign
-1.9
N
REVEL
Pathogenic
0.68
Sift
Benign
0.065
T
Sift4G
Benign
0.13
T
Varity_R
0.18
gMVP
0.83
Mutation Taster
=37/63
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs11214077;
hg19: chr11-111958677;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.